Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 24 , ISSUE 3 ( March, 2020 ) > List of Articles

Original Article

Audit on Practices of Stress Ulcer Prophylaxis in Intensive Care Unit Patients

Divya Gupta, Rahil Singh

Keywords : Critical care, H2 receptor locker, Proton pump inhibitor, Stress ulcer bleeding, Sucralfate

Citation Information : Gupta D, Singh R. Audit on Practices of Stress Ulcer Prophylaxis in Intensive Care Unit Patients. Indian J Crit Care Med 2020; 24 (3):160-167.

DOI: 10.5005/jp-journals-10071-23368

License: CC BY-NC 4.0

Published Online: 01-03-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Background: This audit was aimed at studying current practices regarding the use of stress ulcer prophylaxis (SUP) in the Indian critical care setup, with the background aim of raising awareness regarding the use and indications of SUP in critically ill patients. Materials and methods: After registering the trial with the clinical trial registry, India, a structured audit questionnaire containing 26 questions pertaining to SUP was distributed through electronic media among clinicians working in the intensive care units (ICUs) across India. Responses obtained were statistically analyzed. Results: The questionnaire was sent to 550 clinicians. Only 197 responded, of whom 91.4% were anesthesiologists, 5.6% were physicians, and 3% were intensivists. The audit revealed that 33% respondents were unaware of the existing SUP guidelines and around 32% did not have protocols for SUP in their ICU. Sixty-nine percent of respondents felt that all ICU patients must receive SUP and 44.7% opined that it should be started on ICU arrival. Almost 94% knew that early enteral feeding is protective against stress ulceration. Only 24.9% responders agreed that there must be clear indications for SUP, and most of them were unaware of all the potential side effects. Once initiated, 43.7% respondents would stop prophylaxis when no indication was left, whereas 69 respondents would stop on ICU discharge. Conclusion: There is a lack of awareness regarding initiation, choice of agent, adverse effects as well as termination of SUP in ICU and guidelines for the same. Institutional protocols should be in place and steps need to be taken to prevent unwarranted use.

  1. ASHP Commission on Therapeutics. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health-Syst Pharm 1999;56(4):347–379. DOI: 10.1093/ajhp/56.4.347.
  2. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian critical care trials group. N Engl J Med 1994;330(6):377–381. DOI: 10.1056/NEJM199402103300601.
  3. Barletta JF, Mangram AJ, Sucher JF, Zach V. Stress ulcer prophylaxis in neurocritical care. Neurocrit Care 2018;29(3):344–357. DOI: 10.1007/s12028-017-0447-y.
  4. Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care 2005;20(1):35–45. DOI: 10.1016/j.jcrc.2004.10.003.
  5. Bardou M, Quenot JP, Barkun A. Stress-related mucosal disease in the critically ill patient. Nat Rev Gastroenterol Hepatol 2015;12(2):98–107. DOI: 10.1038/nrgastro.2014.235.
  6. Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med 2002;30(Supplement):S351–S355. DOI: 10.1097/00003246-200206001-00002.
  7. Buendgens L, Koch A, Tacke F. Prevention of stress-related ulcer bleeding at the intensive care unit: risks and benefits of stress ulcer prophylaxis. World J Crit Care Med 2016;5(1):57–64. DOI: 10.5492/wjccm.v5.i1.57.
  8. Plummer MP, Blaser A, Deane A. Stress ulceration: prevalence, pathology and association with adverse outcomes. Crit Care 2014;18(2):213–219. DOI: 10.1186/cc13780.
  9. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41(2):580–637. DOI: 10.1097/CCM.0b013e31827e83af.
  10. Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301–1308. DOI: 10.1056/NEJM200005043421801.
  11. Cook DJ, Griffith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001;5(6):368–375. DOI: 10.1186/cc1071.
  12. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 2008;135(1):41–60. DOI: 10.1053/j.gastro.2008.05.030.
  13. Krag M, Perner A, Wetterslev J, Wise MP, Borthwick M, Bendel S, et al. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med 2015;41(5):833–845. DOI: 10.1007/s00134-015-3725-1.
  14. Mohebbi L, Hesch K. Stress ulcer prophylaxis in the intensive care unit. Proc (Bayl Univ Med Cent) 2009;22(4):373–376. DOI: 10.1080/08998280.2009.11928562.
  15. Palm NM, McKinzie B, Ferguson PL, Chapman E, Dorlon M, Eriksson EA, et al. Pharmacologic stress gastropathy prophylaxis may not be necessary in at-risk surgical trauma ICU patients tolerating enteral nutrition. J Intensive Care Med 2018;33(7):424–429. DOI: 10.1177/0885066616678385.
  16. Selvanderan SP, Summers MJ, Finnis ME, Plummer MP, Ali Abdelhamid Y, Anderson MB, et al. Pantoprazole or placebo for stress ulcer prophylaxis (POP-UP): randomized double-blind Exploratory study. Crit Care Med 2016;44(10):1842–1850. DOI: 10.1097/CCM.0000000000001819.
  17. Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU? Curr Opin Crit Care 2009;15(2):139–143. DOI: 10.1097/MCC.0b013e32832978e0.
  18. Rafinazari N, Abbasi S, Farsaei S, Mansourian M, Adibi P. Adherence to stress-related mucosal damage prophylaxis guideline in patients admitted to the intensive care unit. J Res Pharm Pract 2016;5(3):186–192. DOI: 10.4103/2279-042X.185728.
  19. El-Kersh K, Jalil B, McClave SA, Cavallazzi R, Guardiola J, Guilkey K, et al. Enteral nutrition as stress ulcer prophylaxis in critically ill patients: a randomized controlled exploratory study. J Crit Care 2018;43:108–113. DOI: 10.1016/j.jcrc.2017.08.036.
  20. Alhazzani W, Guyatt G, Alshahrani M, Deane AM, Marshall JC, Hall R, et al. Withholding pantoprazole for stress ulcer prophylaxis in critically ill patients: a pilot randomized clinical trial and meta-analysis. Crit Care Med 2017;45(7):1121–1129. DOI: 10.1097/CCM.0000000000002461.
  21. Krag M, Perner A, Wetterslev J, Wise MP, Borthwick M, Bendel S, et al. Stress ulcer prophylaxis with a proton pump inhibitor vs placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial. Trials 2016;17(1):205. DOI: 10.1186/s13063-016-1331-3.
  22. Pongprasobchai S, Kridkratoke S, Nopmaneejumruslers C. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis. J Med Assoc Thai 2009;92:632–637.
  23. Alshamsi F, Belley-Cote E, Cook D, Almenawer SA, Alqahtani Z, Perri D, et al. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 2016;20(1):120. DOI: 10.1186/s13054-016-1305-6.
  24. Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ. Proton pump inhibitors vs histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 2013;41(3):693–705. DOI: 10.1097/CCM.0b013e3182758734.
  25. MacLaren R, Reynolds PM, Allen RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med 2014;174(4):564–574. DOI: 10.1001/jamainternmed.2013.14673.
  26. Alhazzani W, Alshamsi F, Belley-Cote E, et al. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med 2018;44(1):1–11. DOI: 10.1007/s00134-017-5005-8.
  27. Wohlt P, Hansen LA, Fish JT. Inappropriate continuation of stress ulcer prophylactic therapy after discharge. Ann Pharmacother 2007;41(10):1611–1616. DOI: 10.1345/aph.1K227.
  28. Buendgens L, Tacke F. Do we still need pharmacological stress ulcer prophylaxis at the ICU? J Thorac Dis 2017;9(11):4201–4204. DOI: 10.21037/jtd.2017.09.121.
  29. Stepanski M, Palm N. We no longer need to stress ulcer prophylaxis in the critically ill. J Intensive & Crit Care 2017;3(02):2. DOI: 10.21767/2471-8505.100086.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.